Literature DB >> 12463387

QT interval and QT dispersion during the induction of anaesthesia in patients with subarachnoid haemorrhage: a comparison of thiopental and propofol.

P E Tanskanen1, J V Kyttä, T T Randell.   

Abstract

BACKGROUND AND
OBJECTIVE: Thiopental prolongs the QT interval more than propofol, and the two induction agents were compared in patients with subarachnoid haemorrhage predisposed to electrocardiographic abnormalities and cardiac dysrhythmias.
METHODS: Twenty-nine patients were studied randomly. Anaesthesia was induced with either thiopental or propofol and fentanyl; vecuronium was used as a neuromuscular blocking agent. The electrocardiogram and arterial blood pressure were monitored from before the induction of anaesthesia to 2 min after endotracheal intubation.
RESULTS: The median QT interval was at baseline 423 ms in the thiopental group and at 432 ms in the propofol group, and it increased in the thiopental group to 446 ms and decreased in the propofol group to 425 ms (P < 0.01 between groups). After induction and endotracheal intubation, the number of patients with increased QT dispersion was greater in the propofol group (P < 0.05). The incidence of cardiac dysrhythmias was similar in the study groups.
CONCLUSIONS: Thiopental and propofol are equally suitable for the induction of anaesthesia in patients with subarachnoid haemorrhage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12463387     DOI: 10.1017/s0265021502001217

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  2 in total

Review 1.  [Long QT syndrome and anaesthesia].

Authors:  S Rasche; T Koch; M Hübler
Journal:  Anaesthesist       Date:  2006-03       Impact factor: 1.041

2.  The effects of volatile induction and maintenance of anesthesia and selective spinal anesthesia on QT interval, QT dispersion, and arrhythmia incidence.

Authors:  Ender Ornek; Dilsen Ornek; Z Peren Alkent; Abdülselam Ekin; Meleksah Basaran; Bayazit Dikmen
Journal:  Clinics (Sao Paulo)       Date:  2010-06       Impact factor: 2.365

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.